San Antonio, United States
LumaBridge is an oncology-focused CRO that specializes in designing and executing innovative clinical trial solutions for emerging biopharma companies. Founded in 2013 and headquartered in the United States, the company is dedicated to advancing the field of Health Care. With a strong focus on oncology, LumaBridge aims to provide tailored and effective solutions for the unique challenges faced by biopharma companies in the development of new treatments.
As of now, there is no public information available regarding the company's last investment or the investors involved. Despite this, LumaBridge's commitment to providing innovative solutions in the realm of clinical trials positions it as a potentially promising investment opportunity for Venture capital firms looking to support the advancement of biopharma companies and healthcare innovation.
